About Lantheus

Lantheus provides innovative diagnostics, targeted therapeutics and artificial intelligence (AI) solutions that empower clinicians to Find, Fight and Follow® disease. For more than 60 years, Lantheus has delivered life-changing science to patients and providers, going further to improve outcomes and lives.

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.

Lantheus provides a broad portfolio of products, including PYLARIFY® (Piflufolastat F18), a PSMA PET imaging agent for the detection of suspected recurrent or metastatic prostate cancer; PYLARIFY AI™, an artificial intelligence platform that assists in the evaluation of PSMA PET images; DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound enhancing agent for patients with suboptimal echocardiograms; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and AZEDRA® (Iobenguane I 131) for the treatment of certain rare neuroendocrine tumors.

For more information, visit


Cyclotron Operator

March 2021 North Billerica, MA
“Great experience, hands on learning with machines and communicating with different teams of chemists, electricians, maintenance, and managers. Also worked with manufacturing teams, and got trained to be a cyclotron operator and chemical manufacturer. Super flexible hours. ”

Business Analyst Intern

June 2019 North Billerica, MA
“Wonderful work environment with very kind and helpful IT department.”
See All